PUBLISHER: 360iResearch | PRODUCT CODE: 1620672
PUBLISHER: 360iResearch | PRODUCT CODE: 1620672
Photopheresis Product Market by Product (Closed System, Open System), Therapeutic Area (Autoimmune Diseases, Cutaneous T-cell Lymphoma, Graft Versus Host Diseases), End User - Global Forecast 2025-2030
The Photopheresis Product Market was valued at USD 514.34 million in 2023, expected to reach USD 552.19 million in 2024, and is projected to grow at a CAGR of 7.83%, to USD 872.37 million by 2030.
Photopheresis, a therapeutic procedure involving the extracorporeal treatment of blood with UV light and photosensitizing agents, is primarily used to treat conditions like cutaneous T-cell lymphoma, graft versus host disease, and some autoimmune disorders. The global market for photopheresis products is driven by the increasing prevalence of these immune-related disorders, advancements in medical technologies, and a growing emphasis on personalized medicine. Its necessity stems from the need for alternative treatments that offer fewer side effects compared to conventional therapies. The applications span across hospitals, specialty clinics, and ambulatory surgical centers, where it serves as a therapeutic and sometimes preventative measure against disease relapse. End-users mainly include healthcare providers specializing in oncology and hematology. Key growth factors influencing the market include a rising patient pool, increased healthcare spending, and stronger focus on emerging markets where healthcare infrastructure is rapidly developing. Technological innovations, like the integration of AI in photopheresis machines, present notable opportunities. However, market growth is limited by the high cost of devices, stringent regulatory requirements, and a lack of widespread awareness regarding the treatment's benefits. Moreover, skilled professionals are required to operate and manage these sophisticated devices, which can be a limiting factor in underdeveloped regions. Innovative research could target improving the efficacy and affordability of photopheresis equipment and exploring potential new clinical indications. Strategic collaborations with pharmaceutical firms and academic institutions could accelerate product development. Furthermore, increasing outreach and education about photopheresis could help in capturing a larger market share. The market is highly competitive and characterized by continuous innovation, with trends pointing towards a greater integration of digital health solutions to enhance treatment efficacy and patient outcomes.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 514.34 million |
| Estimated Year [2024] | USD 552.19 million |
| Forecast Year [2030] | USD 872.37 million |
| CAGR (%) | 7.83% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Photopheresis Product Market
The Photopheresis Product Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Rising prevalence of autoimmune and cancer diseases
- Increased global healthcare spending and growing awareness about chronic diseases
- Market Restraints
- High costs associated with photopheresis treatments
- Market Opportunities
- Technological advancements in photopheresis products
- Amalgamation activities between photopheresis product manufacturers and healthcare institutions
- Market Challenges
- Regulatory and reimbursement issues associated with photopheresis products and treatments
Porter's Five Forces: A Strategic Tool for Navigating the Photopheresis Product Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Photopheresis Product Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Photopheresis Product Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Photopheresis Product Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Photopheresis Product Market
A detailed market share analysis in the Photopheresis Product Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Photopheresis Product Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Photopheresis Product Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Photopheresis Product Market
A strategic analysis of the Photopheresis Product Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Photopheresis Product Market, highlighting leading vendors and their innovative profiles. These include BioCardia, Inc., Bristol-Myers Squibb Company, Fresenius SE & Co. KGaA, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Macopharma, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., PIT Medical Systems GmbH, Sanofi S.A., Terumo Corporation, and Transimmune AG.
Market Segmentation & Coverage
This research report categorizes the Photopheresis Product Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Closed System and Open System.
- Based on Therapeutic Area, market is studied across Autoimmune Diseases, Cutaneous T-cell Lymphoma, Graft Versus Host Diseases, and Solid Organ Transplant Rejections.
- Based on End User, market is studied across Ambulatory Centers, Hospitals, and Specialty Clinics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of autoimmune and cancer diseases
- 5.1.1.2. Increased global healthcare spending and growing awareness about chronic diseases
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with photopheresis treatments
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in photopheresis products
- 5.1.3.2. Amalgamation activities between photopheresis product manufacturers and healthcare institutions
- 5.1.4. Challenges
- 5.1.4.1. Regulatory and reimbursement issues associated with photopheresis products and treatments
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing adoption of closed systems for increased patient safety
- 5.2.2. End User: Higher need for photopheresis products in hospitals to offer a comprehensive treatment environment
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Photopheresis Product Market, by Product
- 6.1. Introduction
- 6.2. Closed System
- 6.3. Open System
7. Photopheresis Product Market, by Therapeutic Area
- 7.1. Introduction
- 7.2. Autoimmune Diseases
- 7.3. Cutaneous T-cell Lymphoma
- 7.4. Graft Versus Host Diseases
- 7.5. Solid Organ Transplant Rejections
8. Photopheresis Product Market, by End User
- 8.1. Introduction
- 8.2. Ambulatory Centers
- 8.3. Hospitals
- 8.4. Specialty Clinics
9. Americas Photopheresis Product Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Photopheresis Product Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Photopheresis Product Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. Fresenius Kabi Introduces Single-Needle Function in Amicus Separator
- 12.3.2. Japan Approves Reimbursement for Mallinckrodt's CELLEX Photopheresis System in Treating Chronic GVHD
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. BioCardia, Inc.
- 2. Bristol-Myers Squibb Company
- 3. Fresenius SE & Co. KGaA
- 4. Johnson & Johnson Services, Inc.
- 5. Koninklijke Philips N.V.
- 6. Macopharma
- 7. Mallinckrodt Pharmaceuticals
- 8. Merck & Co., Inc.
- 9. Pfizer Inc.
- 10. PIT Medical Systems GmbH
- 11. Sanofi S.A.
- 12. Terumo Corporation
- 13. Transimmune AG
LIST OF FIGURES
- FIGURE 1. PHOTOPHERESIS PRODUCT MARKET RESEARCH PROCESS
- FIGURE 2. PHOTOPHERESIS PRODUCT MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. PHOTOPHERESIS PRODUCT MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. PHOTOPHERESIS PRODUCT MARKET DYNAMICS
- TABLE 7. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY CUTANEOUS T-CELL LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY GRAFT VERSUS HOST DISEASES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SOLID ORGAN TRANSPLANT REJECTIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL PHOTOPHERESIS PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 24. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 25. ARGENTINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 27. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 28. BRAZIL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 29. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 30. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 31. CANADA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 33. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 34. MEXICO PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 37. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 38. UNITED STATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 41. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 42. ASIA-PACIFIC PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 44. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 45. AUSTRALIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 46. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 47. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 48. CHINA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 49. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 50. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 51. INDIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 53. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 54. INDONESIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 56. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 57. JAPAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 59. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 60. MALAYSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 62. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 63. PHILIPPINES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 65. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 66. SINGAPORE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 68. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 69. SOUTH KOREA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 71. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 72. TAIWAN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 74. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 75. THAILAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 77. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 78. VIETNAM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 81. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 82. EUROPE, MIDDLE EAST & AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 84. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 85. DENMARK PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 87. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 88. EGYPT PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 90. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 91. FINLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 93. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 94. FRANCE PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 96. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 97. GERMANY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 99. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 100. ISRAEL PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 101. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 102. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 103. ITALY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 105. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 106. NETHERLANDS PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 108. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 109. NIGERIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 111. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 112. NORWAY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 113. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 114. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 115. POLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 116. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 117. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 118. QATAR PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 120. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 121. RUSSIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 123. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 124. SAUDI ARABIA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 126. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 127. SOUTH AFRICA PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 129. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 130. SPAIN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 132. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 133. SWEDEN PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 135. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 136. SWITZERLAND PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 138. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 139. TURKEY PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 141. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 142. UNITED ARAB EMIRATES PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 144. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
- TABLE 145. UNITED KINGDOM PHOTOPHERESIS PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 146. PHOTOPHERESIS PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 147. PHOTOPHERESIS PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023
